BlackRock Inc. acquired 2,740,117 shares of Harrow, Inc. during the second quarter. The new position is valued at approximately $116.37 million according to a recent SEC filing. This investment grants BlackRock a 7.35% ownership stake in the ophthalmic-focused healthcare company.
Total institutional ownership of Harrow now stands at 72.76%.
The disclosure follows Harrow’s August 10 quarterly earnings report. The company exceeded revenue estimates but missed earnings per share expectations.